Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 10Breast Neoplasms 9Hot Flashes 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcopenia 1Precancerous Conditions 1Pain 1Obesity 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Head and Neck Neoplasms 1Chronic Disease 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 340Cisplatin 238Paclitaxel 203Radiotherapy 195Pemetrexed 187Docetaxel 169Gemcitabine 157pembrolizumab 141Erlotinib Hydrochloride 107Etoposide 99Magnetic Resonance Spectroscopy 93Bevacizumab 91Specimen Handling 76Nivolumab 73Radiosurgery 72durvalumab 69Vinorelbine 54osimertinib 53Gefitinib 49Drug Therapy 49atezolizumab 42Irinotecan 42Radiation 40Topotecan 39Biopsy 39Standard of Care 38Cyclophosphamide 38Cetuximab 35Blood Specimen Collection 33Taxes 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lung Neoplasms × Soybean Proteins × Clear all
NCT05771207 2023-03-16

Effects of Protein on Muscle, Gut Microbiota and Clinical Outcome in Patients With Lung Cancer-related Sarcopenia

Peking Union Medical College Hospital

Phase NA Unknown
90 enrolled
Thoracic

Lung Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡